Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
Phase 3
Completed
- Conditions
- Wison's Disease
- Registration Number
- NCT00212368
- Lead Sponsor
- Nobelpharma
- Brief Summary
The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Wilson's disease(adult,infant,pregnant woman)
Read More
Exclusion Criteria
- acute hepatitis
- malignant tumor
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method